FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 127 filers reported holding FLEXION THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,000 | – | 56 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $2,000 | -93.5% | 175 | -89.6% | 0.00% | -100.0% |
Q3 2018 | $31,000 | -77.5% | 1,675 | -68.7% | 0.00% | -83.3% |
Q2 2018 | $138,000 | -38.7% | 5,355 | -40.5% | 0.01% | -40.0% |
Q1 2018 | $225,000 | 0.0% | 9,005 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $225,000 | +16.0% | 9,005 | +12.1% | 0.01% | +25.0% |
Q3 2017 | $194,000 | +88.3% | 8,030 | +58.1% | 0.01% | +100.0% |
Q2 2017 | $103,000 | -5.5% | 5,080 | +24.5% | 0.00% | -20.0% |
Q1 2017 | $109,000 | +58.0% | 4,080 | +11.8% | 0.01% | +66.7% |
Q4 2016 | $69,000 | +76.9% | 3,650 | +82.5% | 0.00% | +50.0% |
Q3 2016 | $39,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |